BAX - Baxter International Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Baxter International Inc.
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $12.39B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.54 | 1.04%
Avg Daily Range (30 D): $0.32 | 1.32%
Avg Daily Range (90 D): $0.41 | 1.77%
Institutional Daily Volume
Avg Daily Volume: 3.42M
Avg Daily Volume (30 D): 5M
Avg Daily Volume (90 D): 5.21M
Trade Size
Avg Trade Size (Sh.): 142
Avg Trade Size (Sh.) (30 D): 92
Avg Trade Size (Sh.) (90 D): 91
Institutional Trades
Total Institutional Trades: 64,550
Avg Institutional Trade: $3.84M
Avg Institutional Trade (30 D): $4.87M
Avg Institutional Trade (90 D): $5.28M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 11
Market Closing Trades
Avg Closing Trade: $20.54M
Avg Closing Trade (30 D): $28.64M
Avg Closing Trade (90 D): $28.67M
Avg Closing Volume: 419.9K
 
News
Oct 6, 2026 @ 12:40 PM
Are Investors Undervaluing Baxter International (B...
Source: Na
Oct 6, 2026 @ 12:40 PM
Is Baxter International (BAX) Stock Outpacing Its ...
Source: Zacks.Com
Sep 29, 2026 @ 11:55 AM
Why Investors Need to Take Advantage of These 2 Me...
Source: Na
Sep 24, 2026 @ 8:58 AM
Veterinary Ophthalmology Equipment Market by Produ...
Source: Researchandmarkets.Com
Sep 10, 2026 @ 12:30 AM
Intravenous Immunoglobulin Market Size Worth USD 3...
Source: Sns Insider
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.07 $.24 $-.02
Diluted EPS $-2.08 $.24 $-.03
Revenue $11.47B $2.96B $2.7B
Gross Profit $3.45B $1.03B $891M
Net Income / Loss $-1063M $126M $-15M
Operating Income / Loss $-274M $217M $66M
Cost of Revenue $8.02B $1.93B $1.81B
Net Cash Flow $384M
PE Ratio    
Splits
May 31, 2001 2:1